TABLE 2.

Description of ADR reports of mAbs vs. non-mAbs.

Characteristic	mAbs N = 575 (%)	Non-mAb N = 15,335 (%)	p value a
Mean age ± SD Age groups (years)	57.94 ± 13.72	57.61 ± 14.28	0.841 b
0–5	3 (0.52)	193 (1.26)	<0.001
6–17	4 (0.70)	231 (1.51)
18–34	26 (4.52)	422 (2.75)
35–59	265 (46.09)	6,685 (43.59)
60–79	254 (44.17)	7,452 (48.59)
≥80	23 (4.00)	308 (2.01)
Sex
Female	328 (57.04)	8,363 (54.54)	0.244
Male	247 (42.96)	6,959 (45.38)
Year
2016	6 (1.04)	1,398 (9.12)	<0.001
2017	19 (3.30)	1834 (11.96)
2018	33 (5.74)	2,455 (16.01)
2019	140 (24.35)	3,865 (25.20)
2020	377 (65.57)	5,783 (37.71)
Disease types
Single	508 (88.35)	13,539 (88.29)	0.965
Multiple	67 (11.65)	1796 (11.71)
Polypharmacy
Polypharmacy	37 (6.43)	940 (6.13)	0.765
Non-polypharmacy	538 (93.57)	14,395 (93.87)
Past history of ADRs
No	549 (95.48)	14,279 (93.11)	0.027
Yes	26 (4.52)	1,056 (6.89)

^aChi-squared test.

^bT test.